Orchard Therapeutics Statistics
Total Valuation
Bodal Chemicals has a market cap or net worth of INR 8.73 billion. The enterprise value is 17.47 billion.
Market Cap | 8.73B |
Enterprise Value | 17.47B |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Bodal Chemicals has 125.94 million shares outstanding. The number of shares has decreased by -3.28% in one year.
Current Share Class | 125.94M |
Shares Outstanding | 125.94M |
Shares Change (YoY) | -3.28% |
Shares Change (QoQ) | -0.55% |
Owned by Insiders (%) | 60.19% |
Owned by Institutions (%) | 0.07% |
Float | 45.14M |
Valuation Ratios
The trailing PE ratio is 29.55 and the forward PE ratio is 15.06.
PE Ratio | 29.55 |
Forward PE | 15.06 |
PS Ratio | 0.49 |
PB Ratio | 0.79 |
P/TBV Ratio | 0.80 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 59.82 |
EV / Sales | 0.98 |
EV / EBITDA | 9.56 |
EV / EBIT | 15.61 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.82 |
Debt / EBITDA | 4.99 |
Debt / FCF | n/a |
Interest Coverage | 1.37 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 3.50% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 8.34M |
Profits Per Employee | 136,943 |
Employee Count | 2,133 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Bodal Chemicals has paid 40.67 million in taxes.
Income Tax | 40.67M |
Effective Tax Rate | 12.22% |
Stock Price Statistics
The stock price has decreased by -14.50% in the last 52 weeks. The beta is 0.20, so Bodal Chemicals's price volatility has been lower than the market average.
Beta (5Y) | 0.20 |
52-Week Price Change | -14.50% |
50-Day Moving Average | 73.84 |
200-Day Moving Average | 69.05 |
Relative Strength Index (RSI) | 38.67 |
Average Volume (20 Days) | 42,170 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bodal Chemicals had revenue of INR 17.79 billion and earned 292.10 million in profits. Earnings per share was 2.34.
Revenue | 17.79B |
Gross Profit | 8.80B |
Operating Income | 1.12B |
Pretax Income | 332.77M |
Net Income | 292.10M |
EBITDA | 1.83B |
EBIT | 1.12B |
Earnings Per Share (EPS) | 2.34 |
Balance Sheet
The company has 360.60 million in cash and 9.11 billion in debt, giving a net cash position of -8.75 billion or -69.46 per share.
Cash & Cash Equivalents | 360.60M |
Total Debt | 9.11B |
Net Cash | -8.75B |
Net Cash Per Share | -69.46 |
Equity (Book Value) | 11.05B |
Book Value Per Share | 87.60 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 49.49%, with operating and profit margins of 6.29% and 1.64%.
Gross Margin | 49.49% |
Operating Margin | 6.29% |
Pretax Margin | 1.87% |
Profit Margin | 1.64% |
EBITDA Margin | 10.27% |
EBIT Margin | 6.29% |
FCF Margin | n/a |
Dividends & Yields
Bodal Chemicals does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 3.28% |
Shareholder Yield | n/a |
Earnings Yield | 3.35% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on June 10, 2010. It was a forward split with a ratio of 5.
Last Split Date | Jun 10, 2010 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |